This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Journal of Nanobiotechnology Open Access 14 June 2022
-
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
Nature Communications Open Access 14 January 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dorsett, Y. & Tuschl, T. siRNAs: Applications in functional genomics and potential as therapeutics. Nature Rev. Drug Discov. 2, 318–329 (2004).
Potera, C. Antisense – down, but not out. Nature Biotech. 25, 497–499 (2007).
deFougerolles, A. et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nature Rev. Drug Disc. 6, 443–453 (2007).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Melnikova, I. RNA-based therapies. Nat Rev Drug Discov 6, 863–864 (2007). https://doi.org/10.1038/nrd2443
Issue Date:
DOI: https://doi.org/10.1038/nrd2443
This article is cited by
-
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Journal of Nanobiotechnology (2022)
-
Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders
Cellular and Molecular Neurobiology (2022)
-
Inhibition of γ/β Globin Gene Switching in CD 34+ Derived Erythroid Cells by BCL11A RNA Silencing
Indian Journal of Hematology and Blood Transfusion (2019)
-
Induced protein degradation: an emerging drug discovery paradigm
Nature Reviews Drug Discovery (2017)
-
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
Nature Communications (2016)